// App-Quantinova.ai

1580 : Combined neuroendocrine differentiation and androgen receptor hyperactivity in MAP37 and CHD1 null prostate cancer

Researchers

Presenter

  • Leah C. Rider

Principal Investigators

  • Lindsey U. Rodrigues

  • Anis Karimpour-Fard

  • Lina Romero

  • Claire Gillette

  • James C. Costello

  • Scott D. Cramer

Medical Centers

  • University of Colorado Anschutz Medical Campus, Aurora, CO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Enzalutamide

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved